Literature DB >> 17074548

Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen.

David Hubacher1, Veronica Reyes, Sonia Lillo, Ana Zepeda, Pai-Lien Chen, Horacio Croxatto.   

Abstract

OBJECTIVES: This study was undertaken to determine whether 400 mg of prophylactic ibuprofen can alleviate pain from insertion of an intrauterine device (IUD) and to measure level of pain with improved techniques. STUDY
DESIGN: We conducted a randomized, double-blind, placebo-controlled trial of 2019 first-time IUD users: 1008 women received placebo and 1011 women received 400 mg of ibuprofen. Participants took the single tablet at least 45 minutes before IUD insertion. Immediately after insertion, participants recorded level of pain by using a 10-cm visual analog scale, with the value of 10 meaning "worst imaginable pain."
RESULTS: Median level of pain was 1.0 for both ibuprofen and placebo participants; rank test statistics confirmed no difference. Some subgroups of women experienced higher pain (eg, nulliparous women), but ibuprofen still had no important impact on level of pain.
CONCLUSION: Even among first-time users, pain from IUD insertion is generally low. Prophylactic ibuprofen as used in this protocol does not reduce IUD insertion pain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17074548     DOI: 10.1016/j.ajog.2006.08.022

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  24 in total

1.  Failed IUD insertions in community practice: an under-recognized problem?

Authors:  Amna I Dermish; David K Turok; Janet C Jacobson; Marie E S Flores; Molly McFadden; Kathy Burke
Journal:  Contraception       Date:  2012-09-11       Impact factor: 3.375

2.  Paracervical Block for Intrauterine Device Placement Among Nulliparous Women: A Randomized Controlled Trial.

Authors:  Sheila K Mody; John Paul Farala; Berenice Jimenez; Moena Nishikawa; Lynn L Ngo
Journal:  Obstet Gynecol       Date:  2018-09       Impact factor: 7.661

Review 3.  Eliminating health disparities in unintended pregnancy with long-acting reversible contraception (LARC).

Authors:  Caitlin Parks; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2016-02-12       Impact factor: 8.661

4.  Inhaled lavender effect on anxiety and pain caused from intrauterine device insertion.

Authors:  Mahnaz Shahnazi; Roya Nikjoo; Parisa Yavarikia; Sakineh Mohammad-Alizadeh-Charandabi
Journal:  J Caring Sci       Date:  2012-11-28

Review 5.  Intrauterine anesthesia for gynecologic procedures: a systematic review.

Authors:  Rebecca J Mercier; Matthew L Zerden
Journal:  Obstet Gynecol       Date:  2012-09       Impact factor: 7.661

6.  Objective Assessment of Cervical Stiffness after Administration of Misoprostol for Intrauterine Contraceptive Insertion.

Authors:  S Badir; E Mazza; M Bajka
Journal:  Ultrasound Int Open       Date:  2016-05-03

7.  Cervical lidocaine for IUD insertional pain: a randomized controlled trial.

Authors:  Colleen P McNicholas; Tessa Madden; Qiuhong Zhao; Gina Secura; Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2012-09-20       Impact factor: 8.661

8.  Effectiveness of Intrauterine Lignocaine in Addition to Paracervical Block for Pain Relief during Dilatation and Curettage, and Fractional Curettage.

Authors:  Aashima Arora; Ajitabh Shukla; Subhas Chander Saha
Journal:  J Obstet Gynaecol India       Date:  2015-01-22

9.  Ketorolac for Pain Control With Intrauterine Device Placement: A Randomized Controlled Trial.

Authors:  Lynn L Ngo; Kristy K Ward; Sheila K Mody
Journal:  Obstet Gynecol       Date:  2015-07       Impact factor: 7.661

10.  The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability.

Authors:  Megan N Beatty; Paul D Blumenthal
Journal:  Ther Clin Risk Manag       Date:  2009-08-03       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.